Studies indicated that the risk increased with higher cumulative doses and longer duration of use (specifically more than 12 months).
Research has suggested that long-term use of Actos may be associated with a higher risk of developing bladder cancer. ACTOS CANCER
Actos is a brand-name prescription drug (generic name: ) manufactured by Takeda Pharmaceuticals . It belongs to a class of drugs called thiazolidinediones, designed to help adults with type 2 diabetes manage their blood sugar levels by improving insulin sensitivity. 2. The Connection to Bladder Cancer Studies indicated that the risk increased with higher